# Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine

> **NCT00956943** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 87 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Nicoderm CQ transdermal nicotine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00956943
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956943, "Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00956943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*